Download Library

Document Type

Aerie Pharmaceuticals Investor & Media Briefing

View Presentation

View Press Release

View Presentation

Fixed dose combination of AR-13324 and latanoprost (PG324): A double-masked,
randomized, controlled study in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT)

View Presentation

View Transcript

View Presentation

Selective Multi-kinase Inhibitor of ROCK/JAK/PDGFR-B; Reduces
Laser-induced CNV in Rats

Effects of Rho kinase inhibitor AR-13324 on actin cytoskeleton and TGFB2- and CTGF-induced fibrogenic activity
in Human Trabecular Meshwork Cells